Xvivo Perfusion AB (publ) (STO: XVIVO)

Xvivo Perfusion AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	480.77	546.09	246.55	398.7	354.24	159.95
Cash & Short-Term Investments	480.77	546.09	246.55	398.7	354.24	159.95
Cash Growth	180.43%	121.50%	-38.16%	12.55%	121.47%	-14.50%
Accounts Receivable	175.88	98.13	94.5	52.04	40.18	43.73
Other Receivables	-	20.25	9.76	11.88	3.52	5.39
Receivables	175.88	118.37	104.26	63.91	43.7	49.11
Inventory	173.43	141.6	106.57	77.59	59.35	43.87
Prepaid Expenses	-	20.34	10.14	7.34	5.94	6.96
Total Current Assets	830.08	826.41	467.51	547.53	463.23	259.89
Property, Plant & Equipment	120.44	97.55	47.58	26.3	21.33	23.55
Long-Term Investments	-	0.58	0.41	1.16	0.75	0.22
Goodwill	612.66	591.39	625.32	460.23	223.94	65.77
Other Intangible Assets	28.08	30.46	8.49	8.66	6.75	6.22
Long-Term Deferred Tax Assets	-	50.71	39.27	42.17	40.33	12.32
Long-Term Deferred Charges	638.67	598.51	544.51	456.55	393.97	266.52
Other Long-Term Assets	43.05	-	-	-	-	-
Total Assets	2,273	2,196	1,733	1,543	1,150	634.49
Accounts Payable	-	36.05	38.47	21.45	14.47	14.41
Accrued Expenses	-	68.94	52.65	46.96	48.9	31.25
Current Portion of Leases	10.06	10.27	5.55	4.2	3.93	3.4
Current Income Taxes Payable	-	11.87	1.28	0.3	-	-
Current Unearned Revenue	-	3.69	3.17	3.01	3.72	1.78
Other Current Liabilities	190.99	3.66	33.77	28.6	1.24	1.77
Total Current Liabilities	201.05	134.49	134.9	104.52	72.25	52.6
Long-Term Leases	17.13	21.17	4.46	1.52	3.29	2.15
Long-Term Deferred Tax Liabilities	-	29.29	25.77	25.08	24.85	0.9
Other Long-Term Liabilities	30.01	65.62	137.83	126.02	41.46	1.31
Total Liabilities	248.19	250.57	302.95	257.15	141.85	56.97
Common Stock	0.81	0.81	0.76	0.75	0.73	0.68
Additional Paid-In Capital	1,766	1,764	1,314	1,253	1,007	515.75
Retained Earnings	169.55	119.57	27.75	9.28	1.13	44.86
Comprensive Income & Other	88.53	60.89	87.78	22.09	-0.18	16.23
Shareholders' Equity	2,025	1,945	1,430	1,285	1,008	577.52
Total Liabilities & Equity	2,273	2,196	1,733	1,543	1,150	634.49
Total Debt	27.19	31.44	10.01	5.72	7.21	5.55
Net Cash (Debt)	453.58	514.65	236.54	392.98	347.02	154.4
Net Cash Growth	215.31%	117.57%	-39.81%	13.24%	124.76%	-17.46%
Net Cash Per Share	14.74	17.19	8.01	13.58	12.77	5.76
Filing Date Shares Outstanding	31.5	31.5	29.83	29.5	28.72	26.6
Total Common Shares Outstanding	31.5	31.5	29.83	29.5	28.72	26.6
Working Capital	629.03	691.92	332.61	443.01	390.98	207.29
Book Value Per Share	64.28	61.75	47.94	43.58	35.11	21.71
Tangible Book Value	1,384	1,323	796.33	816.56	777.77	505.53
Tangible Book Value Per Share	43.94	42.01	26.69	27.68	27.08	19.00
Machinery	-	153.61	98.52	68.04	58.77	49.75

Source: S&P Capital IQ. Standard template. Financial Sources.